Member Info for nissangtr786

This straightforward non-invasive test is the future of individualised treatment. I am very proud of the team of researchers and clinical staff who have contributed to its success so far. Our ambition is to see this test rolled out across all maternity services in England so that all babies and families can benefit from this test, if needed.

While MFT is the first trust to routinely use the test, other NHS trusts in Greater Manchester will soon follow. Bolton NHS Foundation Trust​, Northern Care Alliance NHS Foundation Trust, Tameside and Glossop Integrated Care NHS Foundation Trust​ and Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust are also set to introduce the revolutionary test in 2023.

…….

They are targeting Manchester area first but are targeting all of England maternity services so how is that misleading?

Interesting to see so many trades last 2 days. That rollout news could be the reason as many now know it is going in many other places soon. I can see this rocket back into the 30’s again or maybe even 40’s like March 2023, especially if DEVOTE funding amount is announced and is huge.

It is priced at what the sell price would be around.

Looking at buys and sells and price it must be a sell. Hopefully that is the big seller out of the way.

1M late sell?

Genedrive is now a great company to takeover. I would be happy if a miracle £1.23 per share takeover bid came. LTH's from over £1 days will be happy and Genedrive will progress faster with a bigger player. Going by the expected revenue, I think £1.23 a share takeover bid is realistic.

Interesting to see what the late buy is at 16:35.

You did a great trade MR when you sold it.

I will take 32p.

Https://www.linkedin.com/posts/genedrive-plc_gdr-nhs-neonatal-activity-7092464486757842944-U5ZD?utm_source=share&utm_medium=member_ios

There was actually news with Budd saying something which may have resulted in this flying due to he rollout happening elsewhere now as well.

https://research.cmft.nhs.uk/news-events/vulnerable-newborns-at-manchester-hospitals-are-first-to-benefit-from-rollout-of-genetic-test-to-prevent-hearing-loss

"While MFT is the first trust to routinely use the test, other NHS trusts in Greater Manchester will soon follow. Bolton NHS Foundation Trust​, Northern Care Alliance NHS Foundation Trust, Tameside and Glossop Integrated Care NHS Foundation Trust​ and Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust are also set to introduce the revolutionary test in 2023."

Now we know where they are introducing it to.

Hoping for a massive rerate.

Still can’t believe this share used to trade at over 50p regularly and now crashes to low amounts after great news. I first bought in at 64p and I hoped back in March 2023 it was gonna hit that again but it crashed quickly again.

Https://www.linkedin.com/posts/genedrive-plc_point-of-care-genetic-testing-to-prevent-activity-7092037904780156928-jGRr?utm_source=share&utm_medium=member_ios

Just hoping it rerates back into the 30’s again and even better the high 40’s like a few months ago. Never thought we would be back to this low again.

Feels like finally a blue day. Would love for it to surge back to 30’s again.

MassiveRay do you think this is gonna rerate again?

It also hit 35p when it was announced.

MassiveRay the drop has been overdone. I am surprised you are invested in GST which is in a far worse position and way overvalued compared to Genedrive. NICE big buy just came in.

Gloriamarket talking nonsense and comedy likenstarresnstoff.

Avacta is worth a lot less in net value than Genedrive and nowhere near ready to sell in market and it has a market capital over 21x it. Avacta should be like 3-4p now in reality going by Genedrive value.